Department of Epidemiology, Colorado School of Public Health, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
Pulmonary Section, Minneapolis Veterans Affairs Health Care System, Minneapolis, Minnesota, USA.
AIDS Res Hum Retroviruses. 2023 Dec;39(12):621-632. doi: 10.1089/AID.2023.0001. Epub 2023 Jun 28.
People living with HIV have greater pulmonary function impairments and decreased health-related quality of life (HRQoL) compared to uninfected peers. We examined whether pulmonary impairment was associated with HRQoL or respiratory health status. Using Multicenter AIDS Cohort Study data (2017-2019), associations between outcomes [HRQoL (36-Item Short Form Survey) and respiratory health status (St. George's Respiratory Questionnaire)] with pulmonary impairment [diffusing capacity for carbon monoxide (DL) and forced expiratory volume in 1 s (FEV), defined as <80% predicted for both] were examined. Adjusted analyses utilized linear and zero-inflated beta regression, the latter summarized by odds ratio (OR) and quotient ratios (QRs). We also considered whether the subset of adjustment variables age, HIV serostatus, or smoking modified the relationships examined. Of 1048 men, 55% had HIV, with median age 57 [interquartile range (IQR) = 48, 64] years and 1.2 (IQR = 0, 18.1) smoking pack-years. Impaired DL, but not impaired FEV was significantly associated with lower physical HRQoL [-2.71 (-4.09, -1.33); -1.46 (-3.45, 0.54), respectively]. Pulmonary impairment was associated with higher odds of any St. George's Respiratory Questionnaire (SGRQ) (total score) limitation [DL OR = 1.53 (1.15, 2.04); FEV OR = 2.48 (1.16, 5.30)] and was elevated in individuals with more severe SGRQ limitations [DL QR = 1.13 (0.94, 1.36); FEV QR = 1.27 (0.98, 1.64)]. HIV did not modify any associations examined. Age modified the DL and any respiratory limitation (SGRQ symptom score) association for every 10 mL CO/min/mmHg decrease in DL [age 30 OR = 1.03 (0.51, 2.08); age 50 OR = 1.85 (1.27, 3.85); and age 70 OR = 3.45 (2.00, 5.88)]. Similarly, age modified the DL and any respiratory limitation (SGRQ total score) association. FEV associations with SGRQ and HRQoL scores were similar across all ages. Impaired pulmonary function was associated with lower HRQoL and greater respiratory impairments. Future studies can determine if interventions aimed at preserving pulmonary function are effective in improving HRQoL and respiratory health among aging men with and without HIV.
与未感染的同龄人相比,HIV 感染者的肺功能损害更大,健康相关生活质量(HRQoL)降低。我们研究了肺功能损害是否与 HRQoL 或呼吸健康状况有关。使用多中心艾滋病队列研究数据(2017-2019 年),研究了结局[HRQoL(36 项简短健康调查)和呼吸健康状况(圣乔治呼吸问卷)]与肺功能损害[一氧化碳弥散量(DL)和 1 秒用力呼气量(FEV),定义为两者均<80%预测值]之间的关联。调整后的分析采用线性和零膨胀 beta 回归,后者由比值比(OR)和商数比(QR)总结。我们还考虑了年龄、HIV 血清状态或吸烟这一组调整变量是否改变了所研究的关系。在 1048 名男性中,55%患有 HIV,中位年龄为 57 岁[四分位间距(IQR)=48,64],吸烟包年数为 1.2(IQR=0,18.1)。DL 受损而非 FEV 受损与较低的生理 HRQoL 显著相关[-2.71(-4.09,-1.33);-1.46(-3.45,0.54)]。肺功能损害与任何圣乔治呼吸问卷(SGRQ)(总分)受限的几率较高相关[DL OR=1.53(1.15,2.04);FEV OR=2.48(1.16,5.30)],并且在 SGRQ 限制更严重的个体中更高[DL QR=1.13(0.94,1.36);FEV QR=1.27(0.98,1.64)]。HIV 并未改变任何研究的相关性。年龄改变了每降低 10ml CO/min/mmHg DL 与任何呼吸限制(SGRQ 症状评分)的关联[年龄 30 OR=1.03(0.51,2.08);年龄 50 OR=1.85(1.27,3.85);年龄 70 OR=3.45(2.00,5.88)]。同样,年龄也改变了 DL 和任何呼吸限制(SGRQ 总分)的关联。FEV 与 SGRQ 和 HRQoL 评分的相关性在所有年龄组中均相似。肺功能损害与较低的 HRQoL 和更大的呼吸损害有关。未来的研究可以确定,旨在保护肺功能的干预措施是否能有效提高 HIV 感染者和非感染者中老年人的 HRQoL 和呼吸健康。